Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2006

01-04-2006 | Review

Epidemiology, risk factors, and lifestyle modifications for gout

Authors: Kenneth G Saag, Hyon Choi

Published in: Arthritis Research & Therapy | Special Issue 1/2006

Login to get access

Abstract

Gout affects more than 1% of adults in the USA, and it is the most common form of inflammatory arthritis among men. Accumulating data support an increase in the prevalence of gout that is potentially attributable to recent shifts in diet and lifestyle, improved medical care, and increased longevity. There are both nonmodifiable and modifiable risk factors for hyperuricemia and gout. Nonmodifiable risk factors include age and sex. Gout prevalence increases in direct association with age; the increased longevity of populations in industrialized nations may contribute to a higher prevalence of gout through the disorder's association with aging-related diseases such as metabolic syndrome and hypertension, and treatments for these diseases such as thiazide diuretics for hypertension. Although gout is considered to be primarily a male disease, there is a more equal sex distribution among elderly patients. Modifiable risk factors for gout include obesity, the use of certain medications, high purine intake, and consumption of purine-rich alcoholic beverages. The increasing prevalence of gout worldwide indicates that there is an urgent need for improved efforts to identify patients with hyperuricemia early in the disease process, before the clinical manifestations of gout become apparent.
Literature
1.
go back to reference Campion E, Glynn R, DeLabry L: Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987, 82: 421-426. 10.1016/0002-9343(87)90441-4.CrossRefPubMed Campion E, Glynn R, DeLabry L: Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987, 82: 421-426. 10.1016/0002-9343(87)90441-4.CrossRefPubMed
2.
go back to reference Roubenoff R, Klag M, Mead L, Liang K, Seidler A, Hochberg M: Incidence and risk factors for gout in white men. JAMA. 1991, 266: 3004-3007. 10.1001/jama.266.21.3004.CrossRefPubMed Roubenoff R, Klag M, Mead L, Liang K, Seidler A, Hochberg M: Incidence and risk factors for gout in white men. JAMA. 1991, 266: 3004-3007. 10.1001/jama.266.21.3004.CrossRefPubMed
3.
go back to reference Hochberg M, Thomas J, Thomas D, Mead L, Levine D, Klag M: Racial differences in the incidence of gout: the role of hypertension. Arthritis Rheum. 1995, 38: 628-632.CrossRefPubMed Hochberg M, Thomas J, Thomas D, Mead L, Levine D, Klag M: Racial differences in the incidence of gout: the role of hypertension. Arthritis Rheum. 1995, 38: 628-632.CrossRefPubMed
4.
go back to reference Arromdee E, Michet C, Crowson C, O'Fallon M, Gabriel S: Epidemiology of gout: is the incidence rising?. J Rheumatol. 2002, 29: 2403-2406.PubMed Arromdee E, Michet C, Crowson C, O'Fallon M, Gabriel S: Epidemiology of gout: is the incidence rising?. J Rheumatol. 2002, 29: 2403-2406.PubMed
5.
go back to reference Adams PF, Hendershot GE, Marano MA, Centers for Disease Control and Prevention/National Center for Health Statistics: Current estimates from the National Health Interview Survey, 1996. Vital Health Stat. 1999, 10: 1-203. Adams PF, Hendershot GE, Marano MA, Centers for Disease Control and Prevention/National Center for Health Statistics: Current estimates from the National Health Interview Survey, 1996. Vital Health Stat. 1999, 10: 1-203.
6.
go back to reference Harris CM, Lloyd DC, Lewis J: The prevalence and prophylaxis of gout in England. J Clin Epidemiol. 1995, 48: 1153-1158. 10.1016/0895-4356(94)00244-K.CrossRefPubMed Harris CM, Lloyd DC, Lewis J: The prevalence and prophylaxis of gout in England. J Clin Epidemiol. 1995, 48: 1153-1158. 10.1016/0895-4356(94)00244-K.CrossRefPubMed
7.
go back to reference Mikuls T, Farrar J, Bilker W, Fernandes S, Saag K: Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology. 2005, 44: 1038-1042. 10.1093/rheumatology/keh679.CrossRefPubMed Mikuls T, Farrar J, Bilker W, Fernandes S, Saag K: Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology. 2005, 44: 1038-1042. 10.1093/rheumatology/keh679.CrossRefPubMed
9.
go back to reference Prior I, Rose B: Uric acid, gout and public health in the South Pacific. NZ Med J. 1966, 65: 295-300. Prior I, Rose B: Uric acid, gout and public health in the South Pacific. NZ Med J. 1966, 65: 295-300.
10.
go back to reference Kim KY, Ralph Schumacher H, Hunsche E, Wertheimer AI, Kong SX: A literature review of the epidemiology and treatment of acute gout. Clin Ther. 2003, 25: 1593-1617. 10.1016/S0149-2918(03)80158-3.CrossRefPubMed Kim KY, Ralph Schumacher H, Hunsche E, Wertheimer AI, Kong SX: A literature review of the epidemiology and treatment of acute gout. Clin Ther. 2003, 25: 1593-1617. 10.1016/S0149-2918(03)80158-3.CrossRefPubMed
12.
go back to reference American Heart Association: Heart Disease and Stroke Statistics, 2004 Update. 2003, Dallas: AHA American Heart Association: Heart Disease and Stroke Statistics, 2004 Update. 2003, Dallas: AHA
13.
go back to reference Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003, 290: 199-206. 10.1001/jama.290.2.199.CrossRefPubMed Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003, 290: 199-206. 10.1001/jama.290.2.199.CrossRefPubMed
14.
go back to reference Rathmann W, Funkhouser E, Dyer AR, Roseman JM: Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: The CARDIA study. Ann Epidemiol. 1998, 8: 250-261. 10.1016/S1047-2797(97)00204-4.CrossRefPubMed Rathmann W, Funkhouser E, Dyer AR, Roseman JM: Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: The CARDIA study. Ann Epidemiol. 1998, 8: 250-261. 10.1016/S1047-2797(97)00204-4.CrossRefPubMed
15.
go back to reference Choi H, Atkinson K, Karlson E, Curhan G: Obesity, weight change, hypertension, diuretic use, and risk of gout in men. Arch Intern Med. 2005, 165: 742-748. 10.1001/archinte.165.7.742.CrossRefPubMed Choi H, Atkinson K, Karlson E, Curhan G: Obesity, weight change, hypertension, diuretic use, and risk of gout in men. Arch Intern Med. 2005, 165: 742-748. 10.1001/archinte.165.7.742.CrossRefPubMed
16.
go back to reference Tykarski A: Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron. 1991, 59: 364-368.CrossRefPubMed Tykarski A: Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron. 1991, 59: 364-368.CrossRefPubMed
17.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee, et al: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee, et al: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed
18.
go back to reference Kim C, Beckles GL: Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System. Am J Prev Med. 2004, 27: 1-7. 10.1016/j.amepre.2004.03.008.CrossRefPubMed Kim C, Beckles GL: Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System. Am J Prev Med. 2004, 27: 1-7. 10.1016/j.amepre.2004.03.008.CrossRefPubMed
19.
go back to reference Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R: The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000, 43: 103-108. 10.1002/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C.CrossRefPubMed Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R: The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000, 43: 103-108. 10.1002/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C.CrossRefPubMed
20.
go back to reference Wallace K, Riedel A, Joseph-Ridge N, Wortmann R: Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004, 31: 1582-1587.PubMed Wallace K, Riedel A, Joseph-Ridge N, Wortmann R: Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004, 31: 1582-1587.PubMed
21.
go back to reference Mikkelsen W, Dodge H, Valkenburg H: The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia, Tecumseh, Michigan 1959–1960. Am J Med. 1965, 39: 242-251. 10.1016/0002-9343(65)90048-3.CrossRefPubMed Mikkelsen W, Dodge H, Valkenburg H: The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia, Tecumseh, Michigan 1959–1960. Am J Med. 1965, 39: 242-251. 10.1016/0002-9343(65)90048-3.CrossRefPubMed
22.
go back to reference Lin KC, Lin HY, Chou P: Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol. 2000, 27: 1045-1050.PubMed Lin KC, Lin HY, Chou P: Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol. 2000, 27: 1045-1050.PubMed
23.
go back to reference Yu TF, Gutman AB: Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms of excretion of urate in man. J Clin Invest. 1959, 38: 1298-1313.PubMedCentralCrossRefPubMed Yu TF, Gutman AB: Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms of excretion of urate in man. J Clin Invest. 1959, 38: 1298-1313.PubMedCentralCrossRefPubMed
24.
go back to reference Burack DA, Griffith BP, Thompson ME, Kahl LE: Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med. 1992, 92: 141-146. 10.1016/0002-9343(92)90104-J.CrossRefPubMed Burack DA, Griffith BP, Thompson ME, Kahl LE: Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med. 1992, 92: 141-146. 10.1016/0002-9343(92)90104-J.CrossRefPubMed
25.
go back to reference Abdelrahman M, Rafi A, Ghacha R, Youmbissi JT, Qayyum T, Karkar A: Hyperuricemia and gout in renal transplant recipients. Ren Fail. 2002, 24: 361-367. 10.1081/JDI-120005370.CrossRefPubMed Abdelrahman M, Rafi A, Ghacha R, Youmbissi JT, Qayyum T, Karkar A: Hyperuricemia and gout in renal transplant recipients. Ren Fail. 2002, 24: 361-367. 10.1081/JDI-120005370.CrossRefPubMed
26.
27.
go back to reference Baroletti S, Bencivenga GA, Gabardi S: Treating gout in kidney transplant recipients. Prog Transplant. 2004, 14: 143-147.CrossRefPubMed Baroletti S, Bencivenga GA, Gabardi S: Treating gout in kidney transplant recipients. Prog Transplant. 2004, 14: 143-147.CrossRefPubMed
28.
go back to reference Hollander AA, van Saase JL, Kootte AM, van Dorp WT, van Bockel HJ, van Es LA, van der Woude FJ: Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet. 1995, 345: 610-614. 10.1016/S0140-6736(95)90520-0.CrossRefPubMed Hollander AA, van Saase JL, Kootte AM, van Dorp WT, van Bockel HJ, van Es LA, van der Woude FJ: Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet. 1995, 345: 610-614. 10.1016/S0140-6736(95)90520-0.CrossRefPubMed
29.
go back to reference Peeters P, Sennesael J: Low-back pain caused by spinal tophus: a complication of gout in a kidney transplant recipient. Nephrol Dial Transplant. 1998, 13: 3245-3247. 10.1093/ndt/13.12.3245.CrossRefPubMed Peeters P, Sennesael J: Low-back pain caused by spinal tophus: a complication of gout in a kidney transplant recipient. Nephrol Dial Transplant. 1998, 13: 3245-3247. 10.1093/ndt/13.12.3245.CrossRefPubMed
30.
go back to reference Lin HY, Rocher LL, McQuillan MA, Schmaltz S, Palella TD, Fox IH: Cyclosporin-induced hyperuricemia and gout. N Engl J Med. 1989, 321: 287-292.CrossRefPubMed Lin HY, Rocher LL, McQuillan MA, Schmaltz S, Palella TD, Fox IH: Cyclosporin-induced hyperuricemia and gout. N Engl J Med. 1989, 321: 287-292.CrossRefPubMed
31.
go back to reference Pilmore HL, Faire B, Dittmer I: Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. Transplantation. 2001, 72: 1703-1705. 10.1097/00007890-200111270-00024.CrossRefPubMed Pilmore HL, Faire B, Dittmer I: Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. Transplantation. 2001, 72: 1703-1705. 10.1097/00007890-200111270-00024.CrossRefPubMed
32.
go back to reference Choi H, Atkinson K, Karlson E, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004, 350: 1093-1103. 10.1056/NEJMoa035700.CrossRefPubMed Choi H, Atkinson K, Karlson E, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004, 350: 1093-1103. 10.1056/NEJMoa035700.CrossRefPubMed
33.
go back to reference Choi H, Atkinson K, Karlson E, Willett W, Curhan G: Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004, 363: 1277-1281. 10.1016/S0140-6736(04)16000-5.CrossRefPubMed Choi H, Atkinson K, Karlson E, Willett W, Curhan G: Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004, 363: 1277-1281. 10.1016/S0140-6736(04)16000-5.CrossRefPubMed
34.
go back to reference Choi H, Curhan G: Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2004, 51: 1023-1029. 10.1002/art.20821.CrossRefPubMed Choi H, Curhan G: Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2004, 51: 1023-1029. 10.1002/art.20821.CrossRefPubMed
35.
go back to reference St-Onge MP, Keller KL, Heymsfield SB: Changes in childhood food consumption patterns: a cause for concern in light of increasing body weights. Am J Clin Nutr. 2003, 78: 1068-1073.PubMed St-Onge MP, Keller KL, Heymsfield SB: Changes in childhood food consumption patterns: a cause for concern in light of increasing body weights. Am J Clin Nutr. 2003, 78: 1068-1073.PubMed
36.
go back to reference Dessein P, Shipton E, Stanwix A, Joffe B, Ramokgadi J: Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis. 2000, 59: 539-543. 10.1136/ard.59.7.539.PubMedCentralCrossRefPubMed Dessein P, Shipton E, Stanwix A, Joffe B, Ramokgadi J: Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis. 2000, 59: 539-543. 10.1136/ard.59.7.539.PubMedCentralCrossRefPubMed
37.
go back to reference Glynn RJ, Campion EW, Silbert JE: Trends in serum uric acid levels 1961–1980. Arthritis Rheum. 1983, 26: 87-93.CrossRefPubMed Glynn RJ, Campion EW, Silbert JE: Trends in serum uric acid levels 1961–1980. Arthritis Rheum. 1983, 26: 87-93.CrossRefPubMed
38.
go back to reference Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S: Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes. 1986, 10: 255-64.PubMed Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S: Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes. 1986, 10: 255-64.PubMed
39.
go back to reference Bieber J, Terkeltaub R: On the brink of novel therapeutic options for an ancient disease. Arthritis Rheum. 2004, 50: 2400-2414. 10.1002/art.20438.CrossRefPubMed Bieber J, Terkeltaub R: On the brink of novel therapeutic options for an ancient disease. Arthritis Rheum. 2004, 50: 2400-2414. 10.1002/art.20438.CrossRefPubMed
40.
go back to reference Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among U.S. adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among U.S. adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed
41.
go back to reference Meigs JB, Wilson PW, Nathan DM, D'Agostino Sr RB, Williams K, Haffner SM: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003, 52: 2160-2167.CrossRefPubMed Meigs JB, Wilson PW, Nathan DM, D'Agostino Sr RB, Williams K, Haffner SM: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003, 52: 2160-2167.CrossRefPubMed
42.
go back to reference Sanchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaria J, Nakagawa T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J: Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol. 2002, 283: F1105-1110.CrossRefPubMed Sanchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaria J, Nakagawa T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J: Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol. 2002, 283: F1105-1110.CrossRefPubMed
43.
go back to reference Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999, 131: 7-13.CrossRefPubMed Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999, 131: 7-13.CrossRefPubMed
44.
go back to reference Fang J, Alderman M: Serum uric acid and cardiovascular mortality: NHANES I epidemiologic follow-up study, 1971–1992. JAMA. 2000, 283: 2404-2410. 10.1001/jama.283.18.2404.CrossRefPubMed Fang J, Alderman M: Serum uric acid and cardiovascular mortality: NHANES I epidemiologic follow-up study, 1971–1992. JAMA. 2000, 283: 2404-2410. 10.1001/jama.283.18.2404.CrossRefPubMed
45.
go back to reference Høieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B, for the LIFE Study Group: The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004, 65: 1041-1049. 10.1111/j.1523-1755.2004.00484.x.CrossRefPubMed Høieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B, for the LIFE Study Group: The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004, 65: 1041-1049. 10.1111/j.1523-1755.2004.00484.x.CrossRefPubMed
46.
go back to reference August P: Initial treatment of hypertension. N Engl J Med. 2003, 348: 610-617. 10.1056/NEJMcp010357.CrossRefPubMed August P: Initial treatment of hypertension. N Engl J Med. 2003, 348: 610-617. 10.1056/NEJMcp010357.CrossRefPubMed
47.
go back to reference Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL: Harrison's Principles of Internal Medicine. 2004, New York: McGraw-Hill Professional Publishing, 16 Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL: Harrison's Principles of Internal Medicine. 2004, New York: McGraw-Hill Professional Publishing, 16
48.
50.
go back to reference Griebsch A, Zollner N: Effect of ribomononucleotides given orally on uric acid production in man. Adv Exp Med Biol. 1974, 41: 443-449.CrossRefPubMed Griebsch A, Zollner N: Effect of ribomononucleotides given orally on uric acid production in man. Adv Exp Med Biol. 1974, 41: 443-449.CrossRefPubMed
51.
go back to reference Coe FL, Moran E, Kavalich AG: The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976, 29: 793-800. 10.1016/0021-9681(76)90053-9.CrossRefPubMed Coe FL, Moran E, Kavalich AG: The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976, 29: 793-800. 10.1016/0021-9681(76)90053-9.CrossRefPubMed
52.
go back to reference Emmerson BT: The management of gout. N Engl J Med. 1996, 334: 445-451. 10.1056/NEJM199602153340707.CrossRefPubMed Emmerson BT: The management of gout. N Engl J Med. 1996, 334: 445-451. 10.1056/NEJM199602153340707.CrossRefPubMed
53.
go back to reference Christiansen E, Schnider S, Palmvig B, Tauber-Lassen E, Pedersen O: Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care. 1997, 20: 881-887.CrossRefPubMed Christiansen E, Schnider S, Palmvig B, Tauber-Lassen E, Pedersen O: Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care. 1997, 20: 881-887.CrossRefPubMed
54.
go back to reference Feskens EJ, Kromhout D: Habitual dietary intake and glucose tolerance in euglycaemic men: the Zutphen Study. Int J Epidemiol. 1990, 19: 953-959.CrossRefPubMed Feskens EJ, Kromhout D: Habitual dietary intake and glucose tolerance in euglycaemic men: the Zutphen Study. Int J Epidemiol. 1990, 19: 953-959.CrossRefPubMed
55.
go back to reference Tate GA, Mandell BF, Karmali RA, Laposata M, Baker DG, Schumacher HR, Zurier RB: Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid. Arthritis Rheum. 1988, 31: 1543-1551.CrossRefPubMed Tate GA, Mandell BF, Karmali RA, Laposata M, Baker DG, Schumacher HR, Zurier RB: Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid. Arthritis Rheum. 1988, 31: 1543-1551.CrossRefPubMed
56.
go back to reference Choi HK, Curhan G: Dairy consumption and risk of incident gout in women: The Nurses Health Study [abstract]. Arthritis Rheum. 2005, 52 (suppl 9): S31-S41. Choi HK, Curhan G: Dairy consumption and risk of incident gout in women: The Nurses Health Study [abstract]. Arthritis Rheum. 2005, 52 (suppl 9): S31-S41.
57.
go back to reference Choi HK: Diet, alcohol, and gout: how do we advise patients given recent developments?. Curr Rheumatol Rep. 2005, 7: 220-226.CrossRefPubMed Choi HK: Diet, alcohol, and gout: how do we advise patients given recent developments?. Curr Rheumatol Rep. 2005, 7: 220-226.CrossRefPubMed
58.
go back to reference Mitch WE, Johnson MW, Kirshenbaum JM, Lopez RE: Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther. 1981, 29: 318-321.CrossRefPubMed Mitch WE, Johnson MW, Kirshenbaum JM, Lopez RE: Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther. 1981, 29: 318-321.CrossRefPubMed
59.
go back to reference Berger L, Gerson CD, Yu TF: The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid. Am J Med. 1977, 62: 71-76. 10.1016/0002-9343(77)90351-5.CrossRefPubMed Berger L, Gerson CD, Yu TF: The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid. Am J Med. 1977, 62: 71-76. 10.1016/0002-9343(77)90351-5.CrossRefPubMed
60.
go back to reference Sutton JL, Basu TK, Dickerson JW: Effect of large doses of ascorbic acid in man on some nitrogenous components of urine. Hum Nutr Appl Nutr. 1983, 37: 136-140.PubMed Sutton JL, Basu TK, Dickerson JW: Effect of large doses of ascorbic acid in man on some nitrogenous components of urine. Hum Nutr Appl Nutr. 1983, 37: 136-140.PubMed
61.
go back to reference Stein HB, Hasan A, Fox IH: Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy. Ann Intern Med. 1976, 84: 385-388.CrossRefPubMed Stein HB, Hasan A, Fox IH: Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy. Ann Intern Med. 1976, 84: 385-388.CrossRefPubMed
62.
go back to reference Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, Miller ER: The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized, controlled trial. Arthritis Rheum. 2005, 52: 1843-1847. 10.1002/art.21105.CrossRefPubMed Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, Miller ER: The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized, controlled trial. Arthritis Rheum. 2005, 52: 1843-1847. 10.1002/art.21105.CrossRefPubMed
Metadata
Title
Epidemiology, risk factors, and lifestyle modifications for gout
Authors
Kenneth G Saag
Hyon Choi
Publication date
01-04-2006
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2006
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1907